Improving patient–physician dialog: commentary on the results of the MS Choices survey

por Lugaresi, Alessandra, Ziemssen, Tjalf, Oreja-Guevara, Celia, Thomas, Delyth, Verdun, Elisabetta
Publicado 2012

Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update

por Noval, Susana, Contreras, Inés, Muñoz, Silvia, Oreja-Guevara, Celia, Manzano, Beatriz, Rebolleda, Gema
Publicado 2011

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

por Oreja-Guevara, Celia, Ramos-Cejudo, Jaime, Aroeira, Luiz Stark, Chamorro, Beatriz, Diez-Tejedor, Exuperio
Publicado 2012

Diagnosis and treatment of progressive multiple sclerosis: A position paper

por Pozzilli, Carlo, Pugliatti, Maura, Vermersch, Patrick, Grigoriadis, Nikolaos, Alkhawajah, Mona, Airas, Laura, Oreja‐Guevara, Celia
Publicado 2022

Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis

por Schmierer, Klaus, Wiendl, Heinz, Oreja-Guevara, Celia, Centonze, Diego, Chudecka, Anita, Roy, Sanjeev, Boschert, Ursula
Publicado 2022

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements

por Oreja-Guevara, Celia, Tintoré, Mar, Meca, Virginia, Prieto, José María, Meca, José, Mendibe, Mar, Rodríguez-Antigüedad, Alfredo
Publicado 2023

Clinically Isolated Syndromes Suggestive of Multiple Sclerosis: An Optical Coherence Tomography Study

por Oreja-Guevara, Celia, Noval, Susana, Alvarez-Linera, Juan, Gabaldón, Laura, Manzano, Beatriz, Chamorro, Beatriz, Diez-Tejedor, Exuperio
Publicado 2012

Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism

por Ramos-Cejudo, Jaime, Oreja-Guevara, Celia, Stark Aroeira, Luiz, Rodriguez de Antonio, Luis, Chamorro, Beatriz, Diez-Tejedor, Exuperio
Publicado 2011

Is natalizumab a safe treatment for patients with multiple sclerosis in the COVID-19 pandemic? Data from the first year of the pandemic

por Díaz-Díaz, Judit, Ramirez, Clara Isabel, Ortiz-Pica, Marta, García-Yusta, Elena, Gómez-Estevez, Irene, Oreja-Guevara, Celia
Publicado 2021

Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients

por Díaz-Díaz, Judit, Ramirez, Clara Isabel, Ortiz-Pica, Marta, García-Yusta, Elena, Gómez-Estevez, Irene, Oreja-Guevara, Celia
Publicado 2021

Cognitive Dysfunctions and Assessments in Multiple Sclerosis

por Oreja-Guevara, Celia, Ayuso Blanco, Teresa, Brieva Ruiz, Luis, Hernández Pérez, Miguel Ángel, Meca-Lallana, Virginia, Ramió-Torrentà, Lluís
Publicado 2019

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging

por Matías-Guiu, Jordi A., Oreja-Guevara, Celia, Cabrera-Martín, María Nieves, Moreno-Ramos, Teresa, Carreras, José Luis, Matías-Guiu, Jorge
Publicado 2016

Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel

por Oreja-Guevara, Celia, Rabanal, Aintzane, Rodríguez, Corazón Hernández, Benito, Yolanda Aladro, Bilbao, Mar Mendibe, Gónzalez-Suarez, Inés, Gómez-Palomares, José Luis
Publicado 2023

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts

por Berger, Thomas, Elovaara, Irina, Fredrikson, Sten, McGuigan, Chris, Moiola, Lucia, Myhr, Kjell-Morten, Oreja-Guevara, Celia, Stoliarov, Igor, Zettl, Uwe K.
Publicado 2016

Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges

por D’Angelo, Chiara, Franch, Oriol, Fernández-Paredes, Lidia, Oreja-Guevara, Celia, Núñez-Beltrán, María, Comins-Boo, Alejandra, Reale, Marcella, Sánchez-Ramón, Silvia
Publicado 2019

Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from th...

por Vermersch, Patrick, Oreja‐Guevara, Celia, Siva, Aksel, Van Wijmeersch, Bart, Wiendl, Heinz, Wuerfel, Jens, Buffels, Regine, Kadner, Karen, Kuenzel, Thomas, Comi, Giancarlo
Publicado 2021

Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation

por Matias-Guiu, Jordi A., Cortés-Martínez, Ana, Valles-Salgado, María, Oreja-Guevara, Celia, Pytel, Vanesa, Montero, Paloma, Moreno-Ramos, Teresa, Matias-Guiu, Jorge
Publicado 2017

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

por Centonze, Diego, Rocca, Maria A., Gasperini, Claudio, Kappos, Ludwig, Hartung, Hans-Peter, Magyari, Melinda, Oreja-Guevara, Celia, Trojano, Maria, Wiendl, Heinz, Filippi, Massimo
Publicado 2021

Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide

por Van Wijmeersch, Bart, Hartung, Hans-Peter, Vermersch, Patrick, Pugliatti, Maura, Pozzilli, Carlo, Grigoriadis, Nikolaos, Alkhawajah, Mona, Airas, Laura, Linker, Ralf, Oreja-Guevara, Celia
Publicado 2022

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets

por Yamout, Bassem I, Rieckmann, Peter, Centonze, Diego, Giovannoni, Gavin, Hua, Le H., Oreja-Guevara, Celia, Selchen, Daniel, Sørensen, Per Soelberg, Vermersch, Patrick, Wiendl, Heinz
Publicado 2022